Your browser doesn't support javascript.
loading
Proof-of-principle of a lung sealant based on functionalized polyoxazolines: experiments in an ovine acute aerostasis model.
Hermans, Bob P; Ten Broek, Richard P G; Li, Wilson W L; Roozen, Edwin A; Vos, Shoko; Van Der Heijden, Erik H F M; Van Goor, Harry; Verhagen, Ad F T M.
Afiliação
  • Hermans BP; Department of Cardio-Thoracic Surgery, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, Netherlands.
  • Ten Broek RPG; Department of General Surgery, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, Netherlands.
  • Li WWL; Department of Cardio-Thoracic Surgery, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, Netherlands.
  • Roozen EA; Department of General Surgery, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, Netherlands.
  • Vos S; Department of Pathology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, Netherlands.
  • Van Der Heijden EHFM; Department of Pulmonology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, Netherlands.
  • Van Goor H; Department of General Surgery, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, Netherlands.
  • Verhagen AFTM; Department of Cardio-Thoracic Surgery, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, Netherlands.
Article em En | MEDLINE | ID: mdl-38833687
ABSTRACT

OBJECTIVES:

More effective lung sealants are needed to prevent prolonged pulmonary air leakage (AL). Polyoxazoline-impregnated gelatin patch (N-hydroxysuccinimide ester functionalized poly(2-oxazoline)s; NHS-POx) was promising for lung sealing ex vivo. The aim of this study is to confirm sealing effectiveness in an in vivo model of lung injury.

METHODS:

An acute aerostasis model was used in healthy adult female sheep, involving bilateral thoracotomy, amputation lesions (bronchioles Ø > 1.5 mm), sealant application, digital chest tube for monitoring AL, spontaneous ventilation, obduction and bursting pressure measurement. Two experiments were performed (i) 3 sheep with 2 lesions per lung (N = 4 NHS-POx double-layer, N = 4 NHS-POx single-layer, N = 4 untreated) and (ii) 3 with 1 lesion per lung (N = 3 NHS-POx single-layer, N = 3 untreated). In pooled linear regression, AL was analysed per lung (N = 7 NHS-POx, N = 5 untreated) and bursting pressure per lesion (N = 11 NHS-POx, N = 7 untreated).

RESULTS:

Baseline AL was similar between groups (mean 1.38-1.47 l/min, P = 0.90). NHS-POx achieved sealing in 1 attempt in 8/11 (72.7%) and in 10/11 (90.9%) in >1 attempt. Application failures were only observed on triangular lesions requiring 3 folds around the lung. No influences of methodological variation between experiments was detected in linear regression (P > 0.9). AL over initial 3 h of drainage was significantly reduced for NHS-POx [median 7 ml/min, length of interquartile range 333 ml/min] versus untreated lesions (367 ml/min, length of interquartile range 680 ml/min, P = 0.036). Bursting pressure was higher for NHS-POx (mean 33, SD 16 cmH2O) versus untreated lesions (mean 19, SD 15 cmH2O, P = 0.081).

CONCLUSIONS:

NHS-POx was effective for reducing early AL, and a trend was seen for improvement of bursting strength of the covered defect. Results were affected by application characteristics and lesion geometry.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article